相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cognitive impairment and dementia in Parkinson's disease
Javier Pagonabarraga et al.
NEUROBIOLOGY OF DISEASE (2012)
Attentional Set-Shifting Deficit in Parkinson's Disease Is Associated with Prefrontal Dysfunction: An FDG-PET Study
Yoichi Sawada et al.
PLOS ONE (2012)
Characteristic of Cognitive Decline in Parkinson's Disease: A 1-Year Follow-Up
Audrey McKinlay et al.
APPLIED NEUROPSYCHOLOGY (2011)
Normal and abnormal functions of adenosine receptors in the central nervous system revealed by genetic knockout studies
Catherine J. Wei et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2011)
Effects of Cholinesterase Inhibitors in Parkinson's Disease Dementia: A Review of Clinical Data
Teus van Laar et al.
CNS NEUROSCIENCE & THERAPEUTICS (2011)
Enhanced role of adenosine A2A receptors in the modulation of LTP in the rat hippocampus upon ageing
Ana R. Costenla et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2011)
Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease
Angie A. Kehagia et al.
LANCET NEUROLOGY (2010)
Clinical Efficacy of Istradefylline (KW-6002) in Parkinson's Disease: A Randomized, Controlled Study
Yoshikuni Mizuno et al.
MOVEMENT DISORDERS (2010)
Preferential enhancement of working memory in mice lacking adenosine A2A receptors
Sai-jun Zhou et al.
BRAIN RESEARCH (2009)
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
K. Ray Chaudhuri et al.
LANCET NEUROLOGY (2009)
AGE-RELATED SPATIAL WORKING MEMORY IMPAIRMENT IS CAUSED BY PREFRONTAL CORTICAL DOPAMINERGIC DYSFUNCTION IN RATS
K. Mizoguchi et al.
NEUROSCIENCE (2009)
Adenosine, adenosine A2A antagonists, and Parkinson's disease
P. Jenner et al.
PARKINSONISM & RELATED DISORDERS (2009)
Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies
Reinaldo Naoto Takahashi et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Pharmacological characterization of a novel, potent adenosine A1 and A2A receptor dual antagonist, 5-[5-amino3-(4-fluorophenyl) pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in models of Parkinson's disease and cognition
Takuma Mihara et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Evaluation of distribution of adenosine A2A receptors in normal human brain measured with [11C]TMSX PET
Masahiro Mishina et al.
SYNAPSE (2007)
Th effect of striatal dopamine depletion and the adenosine A2A antagonist KW-6002 on reversal learning in rats
Martin O'Neill et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2007)
Working memory deficits in transgenic rats overexpressing human adenosine A(2A) receptors in the brain
Lydia Gimenez-Llort et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2007)
Mesocortical dopamine modulation of executive functions: beyond working memory
Stan B. Floresco et al.
PSYCHOPHARMACOLOGY (2006)
Comparative studies of huperzine A, donepezil, and rivastigmine on brain acetylcholine, dopamine, norepinephrine, and 5-hydroxytryptamine levels in freely-moving rats
Yan-qi Liang et al.
ACTA PHARMACOLOGICA SINICA (2006)
Improved spatial recognition memory in mice lacking adenosine A2A receptors
Jian Hong Wang et al.
EXPERIMENTAL NEUROLOGY (2006)
Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: A microdialysis study
E Shearman et al.
BRAIN RESEARCH BULLETIN (2006)
Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia
NI Bohnen et al.
JOURNAL OF NEUROLOGY (2006)
Desipramine attenuates working memory impairments induced by partial loss of catecholamines in the rat medial prefrontal cortex
SM Clinton et al.
PSYCHOPHARMACOLOGY (2006)
A systematic review of prevalence studies of dementia in Parkinson's disease
D Aarsland et al.
MOVEMENT DISORDERS (2005)
Antagonistic interaction between adenosine A2A and dopamine D2 receptors modulates the social recognition memory in reserpine-treated rats
RDS Prediger et al.
BEHAVIOURAL PHARMACOLOGY (2005)
Caffeine reverses age-related deficits in olfactory discrimination and social recognition memory in rats -: Involvement of adenosine A1 and A2A receptors
RDS Prediger et al.
NEUROBIOLOGY OF AGING (2005)
Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of Parkinson's disease
P Jenner
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2005)
Activation of adenosine receptors in the posterior cingulate cortex impairs memory retrieval in the rat
GS Pereira et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2005)
Blockade of adenosine A2A receptors reverses short-term social memory impairments in spontaneously hypertensive rats
RDS Prediger et al.
BEHAVIOURAL BRAIN RESEARCH (2005)
Modulation of short-term social memory in rats by adenosine A1 and A2A receptors
RDS Prediger et al.
NEUROSCIENCE LETTERS (2005)
Object recognition impairment in Fmr1 knockout mice is reversed by amphetamine:: involvement of dopamine in the medial prefrontal cortex
R Ventura et al.
BEHAVIOURAL PHARMACOLOGY (2004)
Attention and executive function deficits in chronic low-dose MPTP-treated non-human primates
E Decamp et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Cellular and behavioural effects of the adenosine A2a receptor antagonist KW-6002 in a rat model of L-DOPA-induced dyskinesia
M Lundblad et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Worsening of motor function and mood in a patient with Parkinson's disease after pharmacologic challenge with oral rivastigmine
IH Richard et al.
CLINICAL NEUROPHARMACOLOGY (2002)
Distribution of adenosine A2A receptor antagonist KW-6002 and its effect on gene expression in the rat brain
S Aoyama et al.
BRAIN RESEARCH (2002)
Differential effects of caffeine on dopamine and acetylcholine transmission in brain areas of drug-naive and caffeine-pretreated rats
E Acquas et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Perspectives on object-recognition memory following hippocampal damage: lessons from studies in rats
DG Mumby
BEHAVIOURAL BRAIN RESEARCH (2001)
Effects of rat medial prefrontal cortex temporal inactivation on a delayed alternation task
Y Izaki et al.
NEUROSCIENCE LETTERS (2001)
Adenosine A2A receptor antagonists KF17837 and KW-6002 potentiate rotation induced by dopaminergic drugs in hemi-Parkinsonian rats
K Koga et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Cognitive impairment and the brain dopaminergic system in Parkinson disease -: [18F]fluorodopa positron emission tomographic study
JO Rinne et al.
ARCHIVES OF NEUROLOGY (2000)
Combined use of the adenosine A2A antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys
T Kanda et al.
EXPERIMENTAL NEUROLOGY (2000)
What contributes to quality of life in patients with Parkinson's disease?
A Schrag et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2000)
Systemic administration of adenosine A(2A) receptor antagonist reverses increased GABA release in the globus pallidus of unilateral 6-hydroxydopamine-lesioned rats: A microdialysis study
M Ochi et al.
NEUROSCIENCE (2000)
分享论文
